Pricing Log in Create free account

Caris Life Sciences,�Inc. (CAI) vs Twist Bioscience Corporation (TWST)

Caris Life Sciences,�Inc. and Twist Bioscience Corporation are both Biotechnology companies. Caris Life Sciences,�Inc. and Twist Bioscience Corporation are of similar size ($10.1B and $9.7B). Twist Bioscience Corporation has negative trailing earnings, so its P/E is not meaningful; Caris Life Sciences,�Inc. trades at 91.3×. Caris Life Sciences,�Inc. grew revenue faster over the last twelve months: 96.4% against 19.2%. Caris Life Sciences,�Inc. has the higher net margin (10.6% vs −31.7%) and the higher return on invested capital (50.0% vs −30.8%). Across the 17 metrics below, Caris Life Sciences,�Inc. leads on 16 and Twist Bioscience Corporation on 1.

Valuation

Metric CAI TWST Biotechnology median
P/E 91.33 n/m 12.43
P/S 9.81 22.08 10.53
P/B 16.41 21.39 2.24
Price to free cash flow 78.35 n/m 22.59
EV/EBITDA 51.73 n/m 0.69
EV/Sales 9.41 21.73 9.92
Earnings yield 1.09% (1.45%) (34.94%)
Free cash flow yield 1.28% (1.00%) (23.17%)

Profitability

Metric CAI TWST Biotechnology median
Gross margin 69.66% 51.97% 68.94%
Operating margin 15.49% (33.58%) 0.00%
Net margin 10.62% (31.66%) 0.00%
Free cash flow margin 12.53% (22.15%) 0.00%
Return on equity 20.13% (29.59%) (54.09%)
Return on assets 9.62% (20.78%) (46.84%)
Return on invested capital 49.95% (30.83%) 0.00%

Growth

Metric CAI TWST Biotechnology median
Revenue growth (TTM) 96.36% 19.19% 6.72%
EPS growth (last fiscal year) 69.79% 63.89% 29.36%
Revenue growth, 5-year CAGR — 33.11% 9.96%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CAI TWST Biotechnology median
Debt to equity 0.66 0.03 0.00
Current ratio 5.53 2.67 5.00
Net debt to EBITDA (5.23) 1.95 1.01

Dividend

Metric CAI TWST Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric CAI TWST Biotechnology median
Market cap 9.70b 10.06b 177.44m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack